0001493152-23-045171.txt : 20231215 0001493152-23-045171.hdr.sgml : 20231215 20231215214625 ACCESSION NUMBER: 0001493152-23-045171 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231215 FILED AS OF DATE: 20231215 DATE AS OF CHANGE: 20231215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kucinski Keith A CENTRAL INDEX KEY: 0001763405 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38022 FILM NUMBER: 231492092 MAIL ADDRESS: STREET 1: C/O MATINAS BIOPHARMA HOLDINGS INC. STREET 2: 1545 RT. 206 SOUTH, SUITE 302 CITY: BEDMINSTER STATE: NJ ZIP: 07921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Matinas BioPharma Holdings, Inc. CENTRAL INDEX KEY: 0001582554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 463011414 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1545 ROUTE 206 SOUTH STREET 2: SUITE 302 CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: 908-484-8805 MAIL ADDRESS: STREET 1: 1545 ROUTE 206 SOUTH STREET 2: SUITE 302 CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 ownership.xml X0508 4 2023-12-15 0 0001582554 Matinas BioPharma Holdings, Inc. MTNB 0001763405 Kucinski Keith A C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 0 1 0 0 Chief Financial Officer 0 Stock Option (right to Buy) 0.247 2023-12-15 4 A 0 1000000 0 A 2033-12-15 Common Stock 1000000 1000000 D The option award was made in accordance with the terms of the Issuer's Amended and Restated 2013 Equity Incentive Plan. The option vests as to 25% of the shares on December 15, 2024 with the remaining shares to vest in equal monthly installments on the last day of each month over a period of 36 months commencing December 31, 2024. /s/ Keith A. Kucinski 2023-12-15